FDA 483 - Continental Services Group, Inc. - July 09, 2019

An FDA inspection of Continental Services Group, Inc., a blood bank in Miami, FL, revealed two significant observations. The firm failed to maintain aseptic methods during blood collection, specifically during venipuncture, and also failed to provide adequate private and acoustically protected spaces for donor eligibility examinations.